TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive” or the “Company”) announces that it has completed the second
Toronto, Ontario–(Newsfile Corp. – February 27, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on
Clearmind Medicine Inc., a name synonymous with innovation in the pharmaceutical sector, recently marked a significant milestone in its journey towards redefining therapeutic approaches. On
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative
Even as it’s become clear that an inherited susceptibility to some cancers is more common than once thought, genetic testing of family members of cancer
The colon is often thought of as one organ, but the right and left parts of the colon have different molecular features in cancers.
When people lack visual imagination, this is known as aphantasia. Researchers from the University Hospital Bonn (UKB), the University of Bonn and the German Center
Researchers at the University of Massachusetts Amherst recently released a first-of-its-kind study that focuses on the rare autoimmune disorder aplastic anemia to understand how a
Toronto, Ontario–(Newsfile Corp. – February 27, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a
Researchers have identified this receptor in brain mural cells that regulates reperfusion injury.